首页|期刊导航|皮肤性病诊疗学杂志|表皮生长因子受体酪氨酸激酶抑制剂致痤疮样皮疹3例

表皮生长因子受体酪氨酸激酶抑制剂致痤疮样皮疹3例OA

Three cases of acneiform eruption induced by epidermal growth factor receptor tyrosine ki-nase inhibitors

中文摘要英文摘要

报告由表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)致痤疮样皮疹 3 例.3 例中老年肺癌患者因口服埃克替尼或吉非替尼治疗后均出现不同程度累及面颈部、背部、臀部的痤疮样皮疹就诊.皮肤科检查:患者1 面部可见红斑、丘疹,患者 2 面部可见红斑、丘脓疱疹、脱屑,患者 3 颈部、背部、臀部可见丘疹、红斑、丘脓疱疹.患者 2、3 皮损组织病理检查显示:真皮层见中性粒细胞浸润.患者 1 病理检查缺如.3 例患者均诊断:痤疮样皮疹.3 例患者均予以口服多西环素肠溶胶囊等治疗后皮疹好转,且全程未停止使用 EGFR-TKI.2~3 周后随访,患者皮疹均较前好转.

We report three cases of acneiform eruption induced by EGFR-TKIs.Three middle-aged or elderly patients with lung cancer presented with acneiform eruptions of varying severity in-volving the face,neck,back and buttocks after treatment with icotinib or gefitinib.Dermatological examination revealed erythema and papules on the face in patient 1;erythema,pustules,desqua-mation on the face in patient 2;papules,erythema and pustules on the neck,back and buttocks in patient 3.Histopathological examination of skin lesions from patients 2 and 3 revealed neutro-philic infiltration in the dermis.Histopathological data were unavailable for patient 1.A diagnosis of acneiform eruption was made in all three patients.After treatment with oral doxycycline and oth-er supportive therapies,the eruptions improved.EGFR-TKI was continued throughout dermatolog-ic treatment in all three patients.The skin eruption continued to improve during 2~3 week's fol-low-up.

张明钰;赵慧霞;方红

长治医学院附属和济医院,山西 长治 046011长治医学院附属和济医院,山西 长治 046011浙江大学医学院附属第一医院,浙江 杭州 310000

痤疮样皮疹表皮生长因子受体酪氨酸激酶抑制剂埃克替尼吉非替尼

acneiform eruptionepidermal growth factor receptor tyrosine kinase inhibitorsicotinibgefitinib

《皮肤性病诊疗学杂志》 2026 (8)

600-605,6

10.3969/j.issn.1674-8468.2026.08.007

评论